ATARA BIOTHERAPEUTICS, INC. (ATRA) Operating cash flow 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$50.9MFY2025 · since FY2016: -$60.0M → -$50.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.9M | +25.9% |
| FY2024 | -$68.7M | +64.4% |
| FY2023 | -$193.0M | +28.6% |
| FY2022 | -$270.4M | -22.6% |
| FY2021 | -$220.5M | -22.0% |
| FY2020 | -$180.8M | +23.3% |
| FY2019 | -$235.6M | -31.1% |
| FY2018 | -$179.8M | -105.4% |
| FY2017 | -$87.5M | -45.8% |
| FY2016 | -$60.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net incomeATRA Net marginATRA Gross profitATRA Gross marginATRA Operating incomeATRA Operating marginATRA Free cash flowATRA Capital expendituresATRA Return on equityATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Total liabilitiesATRA Shareholders’ equityATRA overview →